A Curious Case of Anti-D Antibody Titer

Authors

  • Jennifer G. Hensley CNM, WHNP, EdD,

    Corresponding author
    1. Jennifer G. Hensley, CNM, WHNP, EdD, is an Assistant Professor at the University of Colorado Denver in the College of Nursing, Aurora, CO.
      University of Colorado Denver, College of Nursing, Education 2 North, 13120 E. 19th St., Box C-288, Aurora, CO 80045. E-mail: jennifer.hensley@UCDenver.edu
    Search for more papers by this author
  • Katherine P. Coughlin CNM, MSN,

    1. Katherine P. Coughlin, CNM, MSN, is a certified nurse-midwife at Evans Army Community Hospital, Ob/Gyn Careline, Fort Carson, CO.
    Search for more papers by this author
  • Laura L. Klein MD

    1. Laura L. Klein, MD, FACOG, is a Maternal-Fetal Medicine specialist at Pikes Peak Maternal-Fetal Medicine at Memorial Health System, Colorado Springs, CO.
    Search for more papers by this author

University of Colorado Denver, College of Nursing, Education 2 North, 13120 E. 19th St., Box C-288, Aurora, CO 80045. E-mail: jennifer.hensley@UCDenver.edu

Abstract

RhD alloimmunization remains a threat to 1% of the 10% of RhD-negative women in the United States who are giving birth to RhD-positive fetuses despite routine antenatal and postpartum administration of RhoD immune globulin (RhIG). This report examines the clinical course of an RhD-negative woman who developed a high anti-D antibody titer during her pregnancy while carrying an RhD-positive female fetus yet had a negative antibody screen at the time she gave birth. Although she delivered a healthy newborn unaffected by hemolytic disease, subsequent pregnancies will be treated as though she is RhD alloimmunized. The discussion below includes possible causes for the abrupt rise in this woman's anti-D antibody titer, a review of the complex Rh system and cellular anamnestic response, and current fetal surveillance for hemolytic disease of the fetus and newborn.

Ancillary